Consolidation with 90 Yttrium‐ibritumomab tiuxetan after bendamustine and rituximab for relapsed follicular lymphoma

Author:

Miura Katsuhiro1ORCID,Tsujimura Hideki2,Masaki Yasufumi3,Iino Masaki4ORCID,Takizawa Jun5,Maeda Yoshinobu6,Yamamoto Kazuhiko7,Tamura Shinobu8,Yoshida Akiyo9,Yagi Hideo10,Yoshida Isao11,Kitazume Koichi12,Masunari Taro13,Choi Ilseung14,Kakinoki Yasutaka15,Suzuki Ritsuro16,Yoshino Tadashi17,Nakamura Shigeo18,Hatta Yoshihiro1,Yoshida Takashi19,Kanno Masatoshi20

Affiliation:

1. Division of Hematology and Rheumatology, Department of Medicine Nihon University School of Medicine Tokyo Japan

2. Division of Medical Oncology, Chiba Cancer Center Chiba Japan

3. Department of Hematology and Immunology Kanazawa Medical University Ishikawa Japan

4. Department of Medical Oncology Yamanashi Prefectural Central Hospital Kofu Japan

5. Department of Hematology, Endocrinology and Metabolism Niigata University Faculty of Medicine Niigata Japan

6. Department of Hematology and Oncology Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama Japan

7. Department of Hematology Okayama City Hospital Okayama Japan

8. Department of Hematology/Oncology Kinan Hospital Tanabe Japan

9. Department of Hematology Toyama Prefectural Central Hospital Toyama Japan

10. Department of Hematology and Oncology Nara Prefecture General Medical Center Nara Japan

11. Department of Hematologic Oncology National Hospital Organization Shikoku Cancer Center Matsuyama Japan

12. Department of Hematology Showa General Hospital Tokyo Japan

13. Department of Infectious Diseases Chugoku Central Hospital Fukuyama Japan

14. Department of Hematology National Hospital Organization Kyushu Cancer Center Fukuoka Japan

15. Department of Hematology Asahikawa City Hospital Asahikawa Japan

16. Department of Oncology/Hematology Innovative Cancer Center Shimane University Hospital Izumo Japan

17. Department of Pathology Okayama University Graduate School of Medicine, Dentistry and Pharmaceutical Sciences Okayama Japan

18. Department of Pathology and Biological Response Nagoya University Graduate School of Medicine Nagoya Japan

19. Member, Society of Lymphoma Treatment in Japan Kashihara Japan

20. Oncology Center Nara Medical University Hospital Kashihara Japan

Publisher

Wiley

Subject

Cancer Research,Oncology,Hematology,General Medicine

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3